Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.

You are being forwarded in 6s — stay on this page